Correlation Between Collegium Pharmaceutical and Evotec SE

Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Collegium Pharmaceutical and Evotec SE ADR, you can compare the effects of market volatilities on Collegium Pharmaceutical and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Evotec SE.

Diversification Opportunities for Collegium Pharmaceutical and Evotec SE

0.12

Correlation Coefficient

Collegium Pharmaceutical  Evotec SE

Average diversification

The 3 months correlation between Collegium and Evotec is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Evotec SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE ADR and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE ADR has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Evotec SE go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Evotec SE

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 0.89 times more return on investment than Evotec SE. However, Collegium Pharmaceutical is 1.12 times less risky than Evotec SE. It trades about 0.03 of its potential returns per unit of risk. Evotec SE ADR is currently generating about -0.14 per unit of risk. If you would invest  2,861  in Collegium Pharmaceutical on December 29, 2024 and sell it today you would earn a total of  95.00  from holding Collegium Pharmaceutical or generate 3.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Collegium Pharmaceutical  vs.  Evotec SE ADR

Collegium Pharmaceutical

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Collegium Pharmaceutical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, Collegium Pharmaceutical is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Evotec SE ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Evotec SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Collegium Pharmaceutical and Evotec SE

The main advantage of trading using opposite Collegium Pharmaceutical and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.

The idea behind Collegium Pharmaceutical and Evotec SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.